Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: a prospective randomized study

Area of Science:

• Cardiology
• Pharmacology
• Intensive Care Medicine

Background:

• Severe postcardiotomy dysfunction complicates cardiac surgery, leading to significant morbidity and mortality.
• Prolonged support with intra-aortic balloon pump (IABP) and inotropes is often required.
• Early postoperative intervention strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the impact of angiotensin converting enzyme (ACE) inhibitor therapy on patients with severe postcardiotomy dysfunction.
• To assess the effect of captopril on hemodynamic parameters, tissue perfusion, and clinical outcomes.
• To determine the role of ACE inhibitors in the early recovery phase after cardiac surgery.

Main Methods:

• A randomized trial involving 298 patients with prolonged diminished cardiac output post-surgery.
• Patients required support with IABP and inotropes for >48-72 hours.
• Group A received standard IABP and inotropes; Group B received captopril in addition to IABP and inotropes 48-72 hours postoperatively.

Main Results:

• Group B (captopril) showed significant improvement in tissue perfusion and hemodynamics (p < 0.0001).
• Early termination of IABP and inotropes was achieved in Group B (mean 86 hours vs. 169 hours in Group A).
• Hospital mortality decreased from 31% in Group A to 14.5% in Group B; morbidity also reduced (37% vs. 20%).

Conclusions:

• Early postoperative ACE inhibitor administration improves tissue perfusion and reduces mortality, morbidity, and hospital stay in severe postcardiotomy dysfunction.
• ACE inhibitors may facilitate recovery of stunned myocardium by modulating the renin-angiotensin-aldosterone system.
• Further randomized trials are recommended to support routine use of ACE inhibitors in this patient population.